Mobile-Health Network Solutions (Singapore)

The Company is a telehealth solutions provider in Singapore in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application, according to Frost Sullivan.
The Company through its subsidiaries provides telehealth solutions through its MaNaDr platform, which is accessible via its mobile application and website to offer users with a range of seamless and hassle-free telehealth solutions. The platform seeks to offer users the ability to teleconsult with doctors and be prescribed and delivered with the medication at their doorsteps. The Company also sell prescription drugs, non-prescription drugs and healthcare products directly on its platform and indirectly through the Company's retail pharmacy network.
The Company has determined that it has two operating segments: Telemedicine and other services and Sale of medicine and medical devices
- Telemedicine services are provided to both the private sector and public sector. The Company earns telemedicine services revenue from private sector by providing teleconsultation services to patients who have subscribed to MaNadr APP by contractual service providers and sale of prescribed medicine. Telemedicine revenue derived from public sector represents revenue generated from contracts with the relevant authorities and departments of the Singapore government by providing teleconsultation services to patients identified by the authorities and departments of the Singapore government. Telemedicine services with prescribed medicine are two distinct performance obligations with standalone prices that are fixed and paid post rendering of teleconsultation service with patients. Prescribed medicine will be delivered to the customer on the same day. The amount paid by the patient is then allocated to each performance obligation in a contract based on its relative standalone selling price (“SSP”). The SSP is the observable price at which we sell the product or service separately.
- The Company sells prescription drugs, non-prescription drugs and healthcare products to clinics and end customers offline and online. The online transactions are performed through MaNaShop/MaNaStore. These products are purchased by the Company as inventory for onward sale to customers. Revenue from sale of these products under direct sales model is recognized on a gross basis upon delivery of the medicines or products to the customers. For products that are not purchased by the Company as inventory for onward sale to customers through online market model , the Company facilitates setting product prices with vendors. The Company is not responsible for fulfilling the contracts being provided to the customers nor does the Company have inventory risk related to the contracts. Revenue from sales of these products is recognized on a net basis upon delivery of the medicines or products to the customers.
HISTORY
2016 The Company is an investment holding company incorporated on 28 July, 2016 under the laws of the Cayman Islands. The Company is headquartered in Singapore.
2024 The Company has applied to list the company s Class A Ordinary Shares on the Nasdaq Capital Market under the symbol “MNDR.”